What is Alphatec Holdings's market cap?

Alphatec Holdings (ATEC) has a market capitalization of $1.3B and trades on NASDAQ.

What is Alphatec Holdings's revenue and profitability?

Alphatec Holdings generated $787.1M in trailing twelve-month revenue with a net loss of $125.4M, representing a net margin of -15.9%. Gross margin stands at 70.2%, with free cash flow of -$18.1M. These figures are based on the Q1 2026 filing.

Who are Alphatec Holdings's competitors?

Alphatec Holdings's key competitors include Globus Medical, Stryker, Medtronic, and others. These companies compete in similar markets and product categories.

Who does Alphatec Holdings partner with?

Alphatec Holdings's notable partners include Invibio.

What subsidiaries does Alphatec Holdings have?

Alphatec Holdings's subsidiaries include SafeOp, EOS Imaging, Valence.

Where is Alphatec Holdings headquartered?

Alphatec Holdings is headquartered in United States of America and employs approximately 839 people. It has been publicly traded since 2006.

Alphatec Holdings

ATEC

Alphatec Holdings is a medical technology company dedicated to revolutionizing spine surgery through the design and development of approach-specific surgical solutions.

Market cap

$1.33B-15.0%

Revenue$787.1M+22.6%

Net income-$125.4M+24.3%

Free cash flow-$18.1M+90.4%

EPS (diluted)-$0.83+27.8%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$192.1MMiss by $5.4M EPS-$0.22Miss by $0.21

Read the full report

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$211.3M

EPS estimate$0.09

Financials

Q1 2026

Income statement

See full

Revenue$192.1M+13.6%

Gross profit$136.5M+17.7%

Operating income-$22.6M+49.0%

Net income-$33.9M+34.7%

EPS (diluted)-$0.22+37.1%

Balance sheet

See full

Cash & equivalents$139.9M-8.7%

Total debt$603.1M+3.7%

Total equity-$5.3M+93.8%

Total assets$799.5M+1.8%

Cash flow

See full

Operating cash flow$1.3M+126%

CapEx$12.1M+21.7%

Free cash flow-$10.8M+27.9%

Valuation & ratios

Valuation

See full

Market cap$1.33B-15.0%

Enterprise value$1.8B-13.0%

P/S1.7×-0.7×

Profitability

See full

Gross margin70.2%+1.2pp

Operating margin-7.7%-3.0pp

Net margin-15.9%-4.4pp

Returns & leverage

See full

Current ratio1.9×-0.9×

Segments

By product

See full

Products And Services$192.1M+13.6%

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

Stryker$129.09B-15.7%

Medtronic$107.81B-8.5%

Globus Medical$10.6B+44.5%

Alphatec Holdings$1.3B-18.5%

SI-BONE, Inc.$756.2M+0.8%

Orthofix Medical Inc.$481.0M+7.7%

Carlsmed, Inc.$311.3M-19.0%

By revenue growth

Carlsmed, Inc.+74.9%

Globus Medical+23.5%

Alphatec Holdings+22.6%

SI-BONE, Inc.+16.8%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+8.1%

Orthofix Medical Inc.+2.6%

By net margin

Johnson & Johnson21.48%-3.5pp

Globus Medical18.92%+11.5pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Orthofix Medical Inc.-7.27%+10.5pp

SI-BONE, Inc.-8.1%+6.9pp

Alphatec Holdings-15.93%+9.8pp

Carlsmed, Inc.-57.76%+18.3pp

Profile

Alphatec Holdings is a medical technology company dedicated to revolutionizing spine surgery through the design and development of approach-specific surgical solutions. The company integrates advanced implants and fixation systems with its InformatiX platform to provide surgeons with objective, real-time data to improve clinical outcomes and reproducibility. Its core value proposition centers on a holistic procedural approach that addresses decompression, stabilization, and alignment across the entire continuum of spine care.

Competitive position

A specialized spine-focused innovator gaining market share through approach-specific procedures and integrated digital health platforms.

GeographiesUnited States, Australia, New Zealand, Japan

Customer segmentsHospitals, Healthcare Systems, Surgical Centers

Business modelDirect Sales, Capital Equipment Sales, Consumable Sales

SuppliersThird-party contract manufacturers, PEEK material suppliers (Invibio), Human tissue donors for biologics, Specialized raw material providers (Titanium, Cobalt Chrome)

CustomersHospitals, National healthcare accounts, Spine surgeons, Payors

CountryUnited States of America

Listed2006

Employees839.0

CEOPatrick S. Miles

SectorHealthcare

IndustryMedical - Devices

Websiteatecspine.com

FilingsSEC EDGAR

Ask your AI about Alphatec Holdings.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alphatec Holdings's market cap?: Alphatec Holdings (ATEC) has a market capitalization of $1.3B and trades on NASDAQ.
What is Alphatec Holdings's revenue and profitability?: Alphatec Holdings generated $787.1M in trailing twelve-month revenue with a net loss of $125.4M, representing a net margin of -15.9%. Gross margin stands at 70.2%, with free cash flow of -$18.1M. These figures are based on the Q1 2026 filing.
Who are Alphatec Holdings's competitors?: Alphatec Holdings's key competitors include Globus Medical, Stryker, Medtronic, and others. These companies compete in similar markets and product categories.
Who does Alphatec Holdings partner with?: Alphatec Holdings's notable partners include Invibio.
What subsidiaries does Alphatec Holdings have?: Alphatec Holdings's subsidiaries include SafeOp, EOS Imaging, Valence.
Where is Alphatec Holdings headquartered?: Alphatec Holdings is headquartered in United States of America and employs approximately 839 people. It has been publicly traded since 2006.